Log in to save to my catalogue

[ 18 F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof o...

[ 18 F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_497126e6fe484a14b58f292c7979ad26

[ 18 F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Reactive gliosis is a common pathological hallmark of CNS pathology resulting from neurodegeneration and neuroinflammation. In this study we investigate the capability of a novel monoamine oxidase B (MAO-B) PET ligand to monitor reactive astrogliosis in a transgenic mouse model of Alzheimer`s disease (AD). Furthermore, we performed a pilot study in...

Alternative Titles

Full title

[ 18 F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_497126e6fe484a14b58f292c7979ad26

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_497126e6fe484a14b58f292c7979ad26

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-023-02749-2

How to access this item